Return to Trial Database

BTCRC-GI22-564

Phase 2 Study of Gemcitabine, Cisplatin, Quemliclustat (AB680) and Zimberelimab (AB122) during First-Line Treatment of Advanced Biliary Tract Cancers: Big Ten Cancer Research Consortium BTCRC-GI22-564

Status

Currently Enrolling

Cancer Type(s)

Cholangiocarcinoma

Study Contact

studies@hoosiercancer.org

Trial Locations

All sites in which the trial BTCRC-GI22-564 being conducted in.

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

University of Wisconsin Carbone Cancer Center